Quote this publication Share Print

APROKAM

-
Opinions on drugs - Posted on Jul 12 2013

Reason for request

Inclusion

-


Clinical Benefit

Substantial

Substantial AB


Clinical Added Value

minor

APROKAM 50 mg, powder for solution for injection, provides a minor improvement in actual benefit (IAB IV) compared with standard management of postoperative endophthalmitis associated with cataract surgery.


Contact Us

Évaluation des médicaments

See also